Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Cytokeratin CK 7 and CK 20 expression in pituitary adenomas.

Coons SW, Estrada SI, Gamez R, White WL.

Endocr Pathol. 2005 Fall;16(3):201-10.

PMID:
16299403
2.

Clinical Implications of Accurate Subtyping of Pituitary Adenomas: Perspectives from the Treating Physician.

Gomez-Hernandez K, Ezzat S, Asa SL, Mete Ö.

Turk Patoloji Derg. 2015;31 Suppl 1:4-17. doi: 10.5146/tjpath.2015.01311. Review.

3.

Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.

Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S.

Eur J Endocrinol. 2007 Feb;156(2):203-16. Review.

4.

Current pathological classification of pituitary adenomas.

Saeger W.

Acta Neurochir Suppl. 1996;65:1-3. Review.

PMID:
8738481
5.

Classification and pathology of pituitary tumors.

Kontogeorgos G.

Endocrine. 2005 Oct;28(1):27-35. Review.

PMID:
16311407
6.

Clinical Impact of the Current WHO Classification of Pituitary Adenomas.

Saeger W, Honegger J, Theodoropoulou M, Knappe UJ, Schöfl C, Petersenn S, Buslei R.

Endocr Pathol. 2016 Jun;27(2):104-14. doi: 10.1007/s12022-016-9418-7. Review.

PMID:
26860936
7.
8.

Histological features of pituitary adenomas and sellar region masses.

Kleinschmidt-DeMasters BK.

Curr Opin Endocrinol Diabetes Obes. 2016 Dec;23(6):476-484. Review.

PMID:
27763894
9.

Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification.

Saeger W, Petersenn S, Schöfl C, Knappe UJ, Theodoropoulou M, Buslei R, Honegger J.

Endocr Pathol. 2016 Jun;27(2):115-22. doi: 10.1007/s12022-016-9419-6. Review.

PMID:
26874696
10.

Pituitary tumors: prognostic indicators.

Saeger W.

Endocrine. 2005 Oct;28(1):57-66. Review.

PMID:
16311411

Supplemental Content

Support Center